Donanemab leads to modest slowing of Alzheimer's progression, study finds. Iacobucci G. BMJ 2023;382:p1659.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Iacobucci G. Donanemab leads to modest slowing of Alzheimer's progression, study finds. BMJ 2023;382:p1659.
PMID: 37463696